Clinical trials
Observational Myocardial Ischemia trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 7 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 9 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Samsung Medical Center | 10 |
| Yonsei University | 5 |
| Konkuk University Medical Center | 3 |
| Seoul National University Hospital | 3 |
| Chonnam National University Hospital | 2 |
| Hyeon-Cheol Gwon | 1 |
| Jung-min Ahn | 1 |
| Keimyung University Dongsan Medical Center | 1 |
| Seoul St. Mary's Hospital | 1 |
| Seung-Jung Park | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Ischemia | 31 |
| Coronary Artery Disease | 13 |
| Angina, Stable | 4 |
| Coronary Disease | 4 |
| Myocardial Infarction | 4 |
| Angina, Unstable | 3 |
| Heart Diseases | 3 |
| ST Elevation Myocardial Infarction | 3 |
| Cardiovascular Diseases | 2 |
| Non-ST Elevated Myocardial Infarction | 2 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.